FDA product code PQU: Alpha-D-Glucosidase (Gaa) Newborn Screening Test System
PQU is the FDA product code for alpha-d-glucosidase (gaa) newborn screening test system. It is a Class II device, regulated under 21 CFR 862.1488 and reviewed by the Clinical Chemistry panel. Devices under PQU reach the market by 510(k); FDA lists no cleared 510(k)s for it.
Definition
For quantitative measurement of the activity of alpha-D-glucosidase (GAA) from newborn dried blood spot specimens.
Classification
| Field | Value |
|---|---|
| Device name | Alpha-D-Glucosidase (Gaa) Newborn Screening Test System |
| Device class | Class II |
| Regulation | 21 CFR 862.1488 |
| Review panel | CH — Clinical Chemistry |
| Medical specialty | Clinical Chemistry |
| Premarket route | 510(k) |
| Third-party 510(k) review eligible | Yes |
Recalls for PQU devices
FDA recall records list no recalls for product code PQU.
Frequently asked questions
What is FDA product code PQU?
PQU is the FDA product code for alpha-d-glucosidase (gaa) newborn screening test system. It is a Class II device, regulated under 21 CFR 862.1488 and reviewed by the Clinical Chemistry panel.
What device class is PQU?
Class II, regulation 21 CFR 862.1488. Typical premarket route: 510(k).
Next steps
- Run an FDA pathway report with predicate devices for product code PQU
- Run a recall and safety report across every PQU manufacturer
- Watch product code PQU for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Clinical Chemistry product codes · FDA product code lookup · 510(k) database search · 510(k) review times